Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.

Translated title of the contribution: Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.

V. Ratanatharathorn, B. Logan, D. Wang, M. Horowitz, J.P. Uberti, O. Ringden, R.P. Gale, H. Khoury, M. Arora, S. Spellman, C. Cutler, J. Antin, M. Bornhaüser, G. Hale, L.F. Verdonck, M. Cairo, V. Gupta, x CIBMTR, S. Pavletic

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPrior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
Original languageUndefined/Unknown
Pages (from-to)816-824
Number of pages9
JournalBritish Journal of Haematology
Volume145
Issue number6
Publication statusPublished - 2009

Cite this